Pulmonology
Salbutamol Air
Registration certificate:
INN:
Salbutamol
Release form:
Metered Dose Inhaler (MDI)
Therapeutic Area:
Pulmonology
Pharmacotherapeutic Group:
Bronchodilator – selective β2-adrenergic agonist
Conditions for dispensing:
On prescription
Packaging:

Indications for use: 

- Bronchial Asthma: 

  • Relief of asthma symptoms as they occur 
  • Prevention of bronchospasm attacks associated with allergens or physical exertion 
  • Use as part of long-term maintenance therapy for asthma 

- Other Chronic Respiratory Diseases: 

Conditions associated with reversible airway obstruction, including chronic obstructive pulmonary disease (COPD), chronic bronchitis, and emphysema 

This product is included in the Essential Drug List (EDL).

Regulatory Status: Rx only

THERE ARE CONTRAINDICATIONS AND DRUG INTERACTIONS. PLEASE CONSULT A SPECIALIST BEFORE USE.

For the full version of the Salbutamol Air (salbutamol) leaflet, please visit the official website: https://grls.rosminzdrav.ru/Default.aspx

Quality control
at all stages of production